Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients

Bivalirudin, as a direct thrombin inhibitor, is considered to be safer compared with other anticoagulants, such as heparin; however, relevant data in China are unclear. The present study aimed to compare the safety of bivalirudin and heparin as anticoagulants in Chinese patients who underwent percut...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Lina, Liu, Jinjun, Zhang, Yapei, Zhang, Mengying, Wang, Zhenzhen, Wu, Yiping, Bai, Zhichao, Qin, Zhenpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587863/
https://www.ncbi.nlm.nih.gov/pubmed/37869647
http://dx.doi.org/10.3892/etm.2023.12229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587863/
https://www.ncbi.nlm.nih.gov/pubmed/37869647
http://dx.doi.org/10.3892/etm.2023.12229

Ejemplares similares